Study yields molecular clues that could lead to new treatments for rare genetic disease

By | July 6, 2022
​A new stem cell study by KAUST researchers helps to explain a rare genetic disease called Wiskott-Aldrich syndrome (WAS), yielding molecular clues that could lead to new treatments for a devastating immune deficiency disorder.